SLC2A12

Across TCGA cell cohorts, SLC2A12 mutation is significantly associated with the RNA expression of many other genes, with 38 significant associations in total. BLOOD_Leukemia shows the largest number of these associations.

The most reproducible SLC2A12-associated genes across cancer lineages are IL36A, PAX1, and CHST9. Each is linked with SLC2A12 in more than 1 cancer types. Because this analysis shows association rather than direction, both SLC2A12-to-partner and partner-to-SLC2A12 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, IL36A grouped by SLC2A12-low versus SLC2A12-high in BLOOD_Leukemia.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (SLC2A12→partner) and Y-score (partner→SLC2A12) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
BLOOD_Leukemia	IL36A →	+0.914	+3.656	<.001	.006	3	2
BLOOD_Leukemia	PAX1 →	+0.030	+3.890	<.001	<.001	3	1
BLOOD_Leukemia	CHST9 →	+0.018	+3.814	.001	.002	3	1
BLOOD_Leukemia	TRAT1 →	+3.322	+3.491	<.001	.009	3	1
BLOOD_Leukemia	CALHM4 →	+0.020	+3.269	<.001	.007	3	1
BLOOD_Leukemia	KRT6C →	+0.016	+3.359	<.001	.002	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 38 associations by consensus.

IL36A by SLC2A12 expression — BLOOD_Leukemia

Explore this box plot interactively →